Cargando…
Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases
BACKGROUND: To analyze the clinical features, risk factors and outcomes of Aeromonas bloodstream infections (BSIs) in patients with hematological diseases to establish an effective optimal therapy against it. METHODS: A retrospective study was performed by reviewing medical records of patients admit...
Autores principales: | Xu, Chunhui, Lin, Qingsong, Zhao, Yuanqi, Zhu, Guoqing, Jiang, Erlie, Li, Shangzhu, Mi, Yingchang, Zheng, Yizhou, Zhang, Fengkui, Zhu, Xiaofan, Xiao, Zhijian, Han, Mingzhe, Wang, Jianxiang, Feng, Sizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962005/ https://www.ncbi.nlm.nih.gov/pubmed/35351036 http://dx.doi.org/10.1186/s12879-022-07277-7 |
Ejemplares similares
-
Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study
por: Li, Jia, et al.
Publicado: (2023) -
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
por: Zhen, Sisi, et al.
Publicado: (2023) -
Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients
por: Liu, Jia, et al.
Publicado: (2023) -
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
por: Zhang, Lining, et al.
Publicado: (2023) -
P1527: ASSESSMENT OF RISK FACTORS AND ANTIMICROBIAL THERAPY FOR CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN HEMATOLOGICAL PATIENTS
por: Chen, Zhangjie, et al.
Publicado: (2023)